- Home
- ESE vs RNA Comparison
ESE vs RNA Comparison
Compare ESE & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESE
- RNA
- Stock Information
- Founded
- ESE 1990
- RNA 2012
- Country
- ESE United States
- RNA United States
- Employees
- ESE N/A
- RNA N/A
- Industry
- ESE Telecommunications Equipment
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- ESE Telecommunications
- RNA Health Care
- Exchange
- ESE Nasdaq
- RNA Nasdaq
- Market Cap
- ESE 4.8B
- RNA 4.4B
- IPO Year
- ESE N/A
- RNA 2020
- Fundamental
- Price
- ESE $180.85
- RNA $29.31
- Analyst Decision
- ESE Strong Buy
- RNA Strong Buy
- Analyst Count
- ESE 2
- RNA 14
- Target Price
- ESE $187.50
- RNA $68.00
- AVG Volume (30 Days)
- ESE 137.2K
- RNA 1.4M
- Earning Date
- ESE 08-06-2025
- RNA 08-08-2025
- Dividend Yield
- ESE 0.18%
- RNA N/A
- EPS Growth
- ESE 19.62
- RNA N/A
- EPS
- ESE 4.56
- RNA N/A
- Revenue
- ESE $1,071,861,000.00
- RNA $8,927,000.00
- Revenue This Year
- ESE $17.26
- RNA N/A
- Revenue Next Year
- ESE $14.04
- RNA $155.06
- P/E Ratio
- ESE $39.69
- RNA N/A
- Revenue Growth
- ESE 8.40
- RNA N/A
- 52 Week Low
- ESE $101.42
- RNA $21.51
- 52 Week High
- ESE $187.83
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- ESE 58.47
- RNA 42.04
- Support Level
- ESE $180.71
- RNA $31.59
- Resistance Level
- ESE $185.42
- RNA $38.00
- Average True Range (ATR)
- ESE 3.01
- RNA 2.01
- MACD
- ESE -0.85
- RNA -0.59
- Stochastic Oscillator
- ESE 55.28
- RNA 9.67
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.